From the 21st to the 24th of September, EUDRAC will be exhibiting at the RAPS Convergence 2019 in Philadelphia, Birthplace of the USA.

Our team’s experts cover a vast spectrum of expertise, ranging from Small Molecules to Advanced Therapies, and from successful Dossier submissions to the development of Regulatory Strategy. In addition to our deep understanding of the EU, US and Japanese markets, we are also experienced in navigating the peculiarities of the Chinese regulatory landscape.

If you are interested in discussing your potential Regulatory Affairs, Pharmacovigilance and Publishing needs, a member of our Management team will be happy to meet you at booth number 231.